glp-1 medication risks compounding pharmacies Compound versions of drugs for weight loss halted by FDA Congress Introduces SAFE Drugs Act

Clinical trials routinely exclude pregnant and nursing mothers, which means we simply dont have the data needed to establish safety in this population

GLP-1 elicits an intrinsic gut-liver metabolic signal to ameliorate diet-induced VLDL overproduction and insulin resistance

Akkermansia muciniphila WB-STR-0001

Meanwhile, about 3,636 lawsuits have been consolidated into an MDL about whether patients were adequately warned that Zepbound and other GLP-1s could cause severe gut complications

Higher-risk elective patients For patients at higher risk, management should be individualized

Research on GLP-1 Use in People With Bipolar Disorder Is Limited The original randomized, controlled trials for GLP-1s often didnt include participants with bipolar disorder, notes the nonprofit International Bipolar Foundation